/Pfizer%20Inc_%20logo%20on%20iPad-by%20Koshiro%20K%20via%20Shutterstock.jpg)
With a market cap of $144.8 billion, New York-based Pfizer Inc. (PFE) is a global biopharmaceutical company that discovers, develops, and markets innovative medicines and vaccines across diverse therapeutic areas. With a streamlined portfolio post divestitures, it focuses on groundbreaking treatments in oncology, immunology, rare diseases, and infectious diseases.
Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Pfizer fits this criterion perfectly. Pfizer stands out in the market with its innovative pipeline of cutting-edge medicines and vaccines, including advancements in mRNA technology like Comirnaty and Paxlovid, and its focus on addressing unmet medical needs across diverse therapeutic areas. Additionally, its patient-centric initiatives, such as the PfizerForAll platform and partnerships to bridge healthcare disparities, emphasize accessible and equitable care.